|
(4S,5R)-(-)-4-Benzyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone
|
|
857637-92-4
|
|
SKF 97541
|
|
127729-35-5
|
|
(1S,2S)-1,2-Bis(2-hydroxyphenyl)ethylenediamine
|
|
119386-71-9
|
|
S14161
|
|
883046-50-2
|
|
(4S,4''S)-2,2''-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4,5-dihydrooxazole]
|
|
444575-98-8
|
|
SM21 maleate
|
|
155059-42-0
|
|
Silicon(IV) phthalocyanine dichloride
|
|
19333-10-9
|
|
Sodium hexafluoroacetylacetonate
|
|
22466-49-5
|
|
SU4312
|
|
5812-07-7
|
|
(3S,6S)-(+)-3,6-Octanediol
|
|
136705-66-3
|
|
(+)-S-Methyl-L-cysteine-S-oxide
|
|
32726-14-0
|
|
(1S,2S)-(+)-[N,N''-Bis(4-bromobenzyl)-1,2-cyclohexanediamino][(2E)-2-buten-1-yl]chlorosilane
|
|
1072220-37-1
|
|
(S)-(-)-2-(α-(i-butyl)methanamine)-1H-benzimidazole
|
|
59592-31-3
|
|
(S)-2,2'',3,3''-Tetrahydro-1,1''-spirobi[1H-indene]-7,7''-diamine
|
|
885462-88-4
|
|
Silicon(IV) bromide,
|
|
7789-66-4
|
|
SR 3576
|
|
1164153-22-3
|
|
(2S,2'S)-(-)-[N,N'-Bis(2-pyridylmethyl]-2,2'-bipyrrolidine tetrahydrochloride((S,S)-PDP)
|
|
959395-07-4
|
|
SAMS peptide
|
|
125911-68-4
|
|
N-Succinyl-Gly-Gly-Phe-p-nitroanilide
|
|
68982-90-1
|
|
SCH-202676
|
|
70375-43-8
|
|
(S)-Sulforaphene
|
|
592-95-0
|
|
(S)-(-)-2-(α-(i-propyl)methanamine)-1H-benzimidazole
|
|
59653-66-6
|
|
Sodium cobalticarborane
|
|
99492-72-5
|
|
(S)-(-)-2,2''-Bis[di(3,4,5-trimethoxyphenyl)phosphino]-6,6''-dimethoxy-1,1''-biphenyl
|
|
927396-01-8
|
|
(4S,5S)-2-Chloro-3,4-dimethyl-2,5-diphenyl-1-oxa-3-aza-2-silacyclopentane
|
|
680592-40-9
|
|
SCD1 Inhibitor (DMSO solution)
|
|
1032229-33-6
|
|
beta-Secretase Inhibitor II (Z-VLL-CHO)
|
|
263563-09-3
|
|
(S)-2,2''-Dihydroxy-α,α,α,α-tetraphenyl-[1,1-binaphthalene]-3,3-dimethanol
|
|
309269-73-6
|
|
(S)-2,2''-Bis[bis(3,5-dimethylphenyl)phosphino]-4,4'',6,6''-tetramethoxy)-1,1''-biphenyl
|
|
1365531-90-3
|
|
(2S,3S)-1,4-Dioxaspiro[4.5]decane-2,3-diylbis(diphenylmethanol)
|
|
123287-35-4
|
|
SIRT inhibitor 1/2 VII
|
|
143034-06-4
|
|
SNX 482
|
|
203460-30-4
|
|
Satraplatin
|
|
129580-63-8
|
|
SH-5
|
|
701976-54-7
|
|
(4S,5R)-(-)-4-i-Propyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone
|
|
871210-22-9
|
|
(S)-(-)-2,2''-Bis(di-i-propylphosphino)-6,6''-dimethoxy-1,1''-biphenyl
|
|
150971-43-0
|
|
Stichodactyla Toxin
|
|
172450-46-3
|
|
Sulprostone
|
|
60325-46-4
|
|
Sabutoclax
|
|
1228108-65-3
|
|
SB 216641 hydrochloride
|
|
193611-67-5
|
|
1-{(1S,2R)-1-[(11bR)-2,6-Dimethyldinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]-1-phenylpropan-2-yl}-3-phenylurea
|
|
1858223-86-5
|
|
Sulfaquinoxaline-D4
|
|
1329652-02-9
|
|
SB 206553 hydrochloride
|
|
158942-04-2
|
|
SC-51089
|
|
146033-02-5
|
|
SPCK
|
|
65144-34-5
|
|
D-Threitol
|
|
2418-52-2
|
|
SB 699551 dihydrochloride
|
|
791789-61-2
|
|
S-(N-Phenethylthiocarbamoyl)-L-cysteine
|
|
53330-02-2
|
|
(8α,9S)-9-Aminocinchonan-6'-ol
|
|
960050-59-3
|
|
(S)-(+)-4-Chlorodinaphthol[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin
|
|
137156-22-0
|
|
Sodium Dodecylbenzenesulfonate(mixture) solution
|
|
25155-30-0
|
|
(S)-(+)-2,2''-Bis[di(3,5-di-i-propyl-4-dimethylaminophenyl)phosphino]-6,6''-dimethoxy-1,1''-biphenyl
|
|
919338-66-2
|
|
Salsolidine
|
|
493-48-1
|
|
(2S,6S)-2,6-Bis(1,1-dimethylethyl)-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole
|
|
877773-38-1
|
|
(S)-2,2''-Bis[bis(4-methoxy-3,5-di-t-butylphenyl)phosphino]-4,4'',6,6''-tetramethoxy)-1,1''-biphenyl
|
|
1365531-99-2
|
|
STO-609 acetate
|
|
1173022-21-3
|
|
(S)-2,2''-Bis(di-p-tolylphosphino)-4,4'',6,6''-tetramethoxy)-1,1''-biphenyl
|
|
1365531-82-3
|
|
S-(N-Benzylthiocarbamoyl)-L-cysteine
|
|
35446-36-7
|
|
Stresscopin (human)
|
|
352020-03-2
|
|
(3S,5S)-(+)-3,5-Heptanediol
|
|
129212-21-1
|
|
(R)-(+)-SKF38393 hydrochloride
|
|
81702-42-3
|
|
SB 399885 hydrochloride
|
|
402713-80-8
|
|
SM 7368
|
|
380623-76-7
|
|
SH-6
|
|
701976-55-8
|
|
1-{(2S)-1-[(11bR)-Dinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]propan-2-yl}-3-phenylurea
|
|
1357562-63-0
|
|
Sulfo-Cyanine5 maleimide
|
|
2242791-82-6
|
|
1-{(1S,2R)-1-[(11bR)-8,9,10,11,12,13,14,15-Octahydrodinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]-1-phenylpropan-2-yl}-3-phenylurea
|
|
1858224-21-1
|
|
Sodium tetrakis(4-fluorophenyl)borate dihydrate
|
|
207683-22-5
|
|
script
|
|
300816-11-9
|
|
(1S,1''S)-(-)-(Oxybis(2,1-phenylen))bis((2-methoxyphenyl)(phenyl)phosphine)
|
|
2119686-55-2
|
|
Skyrin
|
|
602-06-2
|
|
Substance P free acid
|
|
71977-09-8
|
|
Supercinnamaldehyde
|
|
70351-51-8
|
|
(4S,5S)-2-Allyl-2-chloro-3,4-dimethyl-5-phenyl-1-oxa-3-aza-2-silacyclopentane
|
|
447440-43-9
|
|
(2S,2''S)-(+)-2,2''-Bipyrrolidine
|
|
124779-66-4
|
|
SC 221409
|
|
222035-13-4
|
|
(S)-Sulforaphane
|
|
155320-20-0
|
|
(2S,5S)-1-{[(2S,5S)-2,5-Diethylpyrrolidin-1-yl]methylene}-2,5-diethylpyrrolidinium tetrafluoroborate
|
|
1204324-18-4
|
|
SB 243213 dihydrochloride
|
|
200940-23-4
|
|
(9S)-(9''''S)-9,9''''-[(2,5-diphenyl-4,6-pyrimidinediyl)bis(oxy)]bis[6''-methoxycinchonan]
|
|
1202521-49-0
|
|
SB 242084 hydrochloride
|
|
1260505-34-7
|
|
SHU9119,TFA
|
|
168482-23-3
|
|
Sp-5,6-Dichloro-cBIMPS
|
|
120912-54-1
|
|
SLIGKV-NH2 TFA salt
|
|
190383-13-2
|
|
Sulfo-Cyanine3 azide
|
|
1658416-54-6
|
|
(S)-(+)-2,2''-Bis[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino]-6,6''-dimethoxy-1,1''-biphenyl
|
|
910134-30-4
|
|
(S)-(-)-2-(α-methylmethanamine)-1H-benzimidazole
|
|
925689-54-9
|
|
(S)-2,2'-Bis[bis(3,5-trifluoromethylphenyl)phosphino]-4,4',6,6'-tetramethoxybiphenyl
|
|
1365531-85-6
|
|
Sulfo orange
|
|
547-57-9
|
|
SKI-I
|
|
306301-68-8
|
|
Substance P (7-11)
|
|
51165-05-0
|
|
Sulfo-Cyanine5 carboxylic acid
|
|
1144107-82-3
|
|
S-Farnesyl-L-cysteine methyl ester
|
|
125741-64-2
|
|
Sumanirole maleate
|
|
179386-44-8
|
|
(S)-(-)-2-(α-(t-butyl)methanamine)-1H-benzimidazole
|
|
1118114-88-7
|
|
Sulforhodamine 101 cadaverine trifluoroacetic salt
|
|
203866-87-9
|
|
(S,S)-(-)-1,2-Bis(t-butylmethylphosphino)benzene
|
|
1355162-85-4
|
|
1-{2S)-1-[(11bR)-2,6-Bis(trimethylsilyl)dinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]propan-2-yl}-3-phenylurea
|
|
1357562-70-9
|
|
STA-21 (Ochromycinone)
|
|
28882-53-3
|
|
S14-95
|
|
419532-92-6
|